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Abstract
 
In this paper I want to challenge the effectiveness of the present drugs used for the treatment of
 
depression by challenging the concept that depression is only centered in the brain:treating neurotran-
smitters such as serotonin,norepinephrine,and dopamine. By neglecting other factors that might have
 
even more weight in the cause of depression such as inflammation and the influence of the human gut
 
we are taking away valuable tools away from psychiatrists. Not only should we challenge the way
 
present treatment of depression should be performed using more cognitive and behavioral therapies
 
such as CBT,which operates on the basic principle that a person’s moods and sense of self are
 
intimately linked with their thoughts, and that recognizing dysfunctional thought patterns and
 
replacing them with healthier ones can lead to improvements in mood,but by also giving psychiatrists
 
a different group of medication that might be a more effective tool to help their suffering patients.
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1.Introduction
 
50 years ago the first drug to help people to
 
fight their depression was released to the market
 
and since then many more medications have
 
been appearing after that. Most of these medica-
tions seem to work on the same parts of the
 
brain biology:The neurotransmitters serotonin,
norepinephrine, and dopamine. They seem to
 
work for some people but the results confirm
 
that at least one third of the patients that show
 
major depressive symptoms have not found any
 
relief despite the promise of being able to escape
 
this unbearable suffering. Now come new dis-
coveries that might give us some hope:Inflam-
mation and the knowledge of the importance of
 
the gut.8-11,14,16
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 2.Inflammation and Depression
 
The study of inflammation as a cause of
 
depression began in the early 1990’s but was not
 
able to provide with any strong evidence that it
 
should be pursued. Finally though,this is chang-
ing and for the last five years,research on inflam-
mation and depression 1,3-7,9-19,21-24,26-33 has been ac-
celerating and is finally becoming mainstream.
Even though there is no strong path to show
 
how the two conditions are linked, there is
 
growing evidence that inflammation has a signif-
icant role in depression.3-4,8-10,14,16,18,20-22,24,26-27,29,31,33
 
This evidence is like the sun rising again after
 
a long journey through a dark tunnel to give
 
hope to those who have not found peace of mind
 
in taking all those medications and have on the
 
contrary,being left to suffer terribly.6-7,13,15
 
Physiologically, inflammation seems an un-
likely link to depression and mental problems.
Inflammation,after all,originates from the need
 
of the body to defend itself against infection and
 
injury through the process of white blood cells
 
releasing some chemical compounds that bring
 
blood cells to the location of injury or infection
 
and also immobilizes the affected area and
 
finally raises the temperature to kill invading
 
microbes. These same chemicals induce the
 
body to modify the total behavior of the body to
 
conserve energy for healing but at the same time
 
this process can go wrong and these chemicals
 
can attack the body’s own tissues in autoimmune
 
diseases such as rheumatoid arthritis and ulcerat-
ive colitis. Inflammation has already being
 
linked to other illnesses such as diabetes,heart
 
diseases and even Alzheimer’s.2,8-9
 
Doctors have become more aware of the link
 
between depression and inflammation by observ-
ing patients with prominent inflammation also
 
having high depression rates. This has been also
 
corroborated by studies where healthy people
 
were injected with messenger chemicals such as
 
cytokines,which caused them to have depressive
 
symptoms. At the same time,depressed individ-
uals tend to have elevated blood levels of the pro-
teins that signal chronic inflammation.8-9,17,21-22
 
3.Research Question:Is inflammation
 
the cause or the effect of depression
 
or is it irrelevant?
This question will only be answered if people
 
get relief of their depression after their inflamma-
tion is blocked. So far no definitive studies have
 
proven this. Some drug trials have not being
 
conclusive and even thought some chemical
 
elements such as Curcumin seem promising,they
 
are still in the trial phase.2-3
 
One of the reasons of the lack of success in
 
this search could be the fact that the research did
 
not factor in the fact that inflammation is likely
 
only one part of equation:The Gut, stress, a
 
person’s moods and sense of self which are
 
intimately linked to dysfunctional thought pat-
tern could also have a large say in the mental
 
condition.
We are in need of a novel treatment and this
 
can only occur if we refocus our attention to
 
these different causes, not one, but a combina-
tion of them. According to data from a ten-year
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 study by Avon Longitudinal Study of parents
 
and children monitoring the health of 14,500
 
families in Bristol, England since 1991, shows
 
that excessive inflammatory response makes
 
depression more likely to occur. Children who
 
at age 9 had high levels of the cytokine inter-
leukin-6 or IL-6 were 50 percent more likely to
 
be depressed when they were 18-and the higher
 
their IL-6 level,the greater the depression risk.
These results do not necessarily mean that
 
chronic inflammation caused depression in these
 
young children but that it certainly has shown
 
that it is an important risk factor and this study
 
highlights inflammation as an important piece in
 
the larger puzzle of depression.34-37
 
4.Another piece of the puzzle:The link
 
between stress,inflammation and
 
depression.
A study at Mt.Sinai School of Medicine,the
 
link between stress, inflammation and depres-
sion was highlighted.38  In this experiment, a
 
population of mice had their levels of IL-6
 
determined. They were then put in a highly
 
stressful environment. The mice with higher
 
levels of IL-6,and therefore higher predisposi-
tion to inflammation, were found to be also
 
much more stress-sensitive to the stressful envi-
ronment by entering into a depression-like state
 
of avoidance versus the rats with lower levels of
 
IL-6 levels. This study showed that as with the
 
Avon Study,a naturally elevated inflammatory
 
response of the white cells also indicated that
 
there is a predisposition to depression versus
 
those mice that do not have an elevated inflam-
matory response.
It has been the general belief that inflamma-
tory biomarkers in the blood reflect something
 
occurring in the brain but the above experiment
 
is showing that inflammatory factors in the
 
peripheral circulation could be the actual cause
 
of brain pathology and depression.
Further study to understand the mechanism of
 
the above is needed. One part of this future
 
study should focus on Cytokines like IL-6 than
 
can squeeze through the blood-brain barrier
 
after being carried there by the peripheral leuko-
cytes(white cells). Within the brain,cytokines
 
may interfere with basic communication proces-
ses,such as neurotransmitter release and recep-
tion and with connections between brain
 
regions.
In a recent study published by Jeffrey Meyer
 
et.al.of the University of Toronto for the first
 
time actual evidence of inflammation within the
 
brain was found using positron emission tomo-
graphy(PET)scans that showed higher concen-
trations of translocator protein in the brains of
 
depressed individuals compared to controls.
This protein,he proposed,reflects the activation
 
of microglia,which release inflammatory chemi-
cals. Increased activity was especially marked in
 
brain regions linked to depression symptoms but
 
the correlation was not complete:Translocator
 
protein was elevated in about half of the patients
 
and in 15 percent of the non-depressed controls
 
which could mean that it takes several biological
 
and psychological changes to push someone into
 
a depressive state.
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 The way to proceed studying the influence of
 
inflammation in depression could be to first
 
identify the subgroup of depression sufferers that
 
actually show certain levels of inflammation
 
before treating them. This distinction in future
 
studies could indicate the difference between
 
success and failure.
5.The Gut:Does it dictate your mental
 
health,thoughts and moods?
About half of neurochemicals are actually
 
engaged in gut function,thus regulating appetite,
digestive rate, and metabolism. These neuro-
chemicals include a significant amount of the
 
dopamine and serotonin in our bodies, which
 
are not produced in the brain although used in
 
the brain itself. In truth,most of those neuro-
chemicals are directly managed and produced in
 
the gut.
Initial research has begun to confirm that
 
bacteria can modulate the levels of stress hor-
mones in the body. A preliminary study has
 
showed that having higher levels of two particu-
lar strains of bacteria, bifid bacteria and
 
lactobacillus,are linked to a reduced release of
 
stress hormones into the bloodstream. This test
 
has its basis in lab rats, but the early human
 
experiments with these two strains of bacteria
 
have produced similarly low levels of anxiety in
 
response to typically anxiety-inducing activities.
Ongoing research related to gastroenterology
 
and psychiatric conditions seems to indicate the
 
relationship between elevated levels of a particu-
lar chemical,4-ethylphenylsulphate,also known
 
as 4EPS, which seems to be produced by gut
 
bacteria, and autism. Children with autism
 
demonstrate statistically higher levels of 4EPS
 
than those without,and lab studies have shown
 
that mice injected with concentrated doses of
 
this chemical also began exhibiting autistic
 
symptoms.
The reason that this gut-brain connection
 
matters so much is that for many neurological
 
conditions,no cure is known,but that may be
 
because researchers have been looking in the
 
wrong place. Neurotransmitters, as the name
 
implies, are largely thought of as being in the
 
brain,but as it turns out,the gut also produces
 
important neurotransmitters that can affect
 
social behavior and brain chemistry. By narrow-
ing down the candidates for a link between gut
 
bacteria and autism,researchers could theoreti-
cally eliminate those bacteria,and the chemical
 
that they produce, thus minimizing or even
 
reversing the symptoms of autism.
Other research has even linked our psycholog-
ical response to emotional stimuli to the pres-
ence or absence of gut bacteria. In a controlled
 
study,two groups were given a probiotic and a
 
placebo,respectively. When later shown images
 
of people with emotional facial expressions,
those who had been given?the probiotic were
 
more aware and responsive to emotions, some-
thing that people with an autism spectrum dis-
order often struggle with.9-10,18
 
That being said,the exact mechanisms behind
 
much of this gut-brain interaction are not under-
stood. Theories include a key connection
 
between bacteria and the vagus nerve(control-
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 ling digestive contraction and sensory input to
 
the brain),but this has yet to be proven. The
 
most recent research has focused on the wide
 
range of metabolites, the drug-like chemicals
 
that are produced by microflora that could
 
potentially mimic, counter or complement the
 
traditional neurotransmitters.
It is important to remember that evolution is
 
typically extremely efficient-over a long enough
 
timescale. Therefore, to improve its ability to
 
reproduce,spread and survive,bacteria has like-
ly altered our brain chemistry in myriad ways
 
over time, perhaps even driving our social
 
behavior to form communities and settle in close
 
proximity to other potential hosts.
6.Proposal for a possible research
 
approach
 
Chart 1 is an Observational/Prospective app-
roach research setup that could be used as a base
 
to investigate further the outcome of 2 different
 
therapy treatments based on DNA blood sam-
ples with similar markers for inflammation and
 
gut flora contents.
Conclusion
 
What Does This All Mean?
If we can understand which types of gut
 
bacteria control what moods, emotions and
 
chemical signals within the body that affect
 
brain function, we could theoretically tailor a
 
healthy bacterial balance in the stomach. Essen-
tially, it could be possible to reverse or even
 
inhibit certain chronic psychological or mental
 
disorders. If inflammation does play a role in
 
depression as the nascent research seems to indi-
cate, professionals in Japan would be able to
 
count with one more tool to alleviate this pain-
CHART 1
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ful disease instead of to prescribing into the dark
 
and hoping that the medication they are handing
 
out will solve the patient’s depression. The more
 
we learn about inflammation and bacteria, the
 
more we realize that it does far more than digest
 
our food - it dictates the way we experience,
think about and approach the world around us.
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